What's Next For Rigetti Computing Stock?
Axe Capital view
Quantum Computing’s Long Road: What Rigetti Means for SA Investors
Rigetti Computing’s struggles highlight why speculative tech needs a cautious eye, especially from a South African perspective.
Rigetti Computing’s stock collapse from $56 to $14 is a textbook case of high hopes colliding with harsh realities. The company’s big spend on research ($19.9 million in Q1) dwarfs the $4.4 million in revenue, and that’s a red flag for investors expecting near-term profits. Their $569 million in cash is comforting but won’t last forever without meaningful commercial breakthroughs. From a South African angle, there’s no direct JSE equivalent, so the rand’s strength against the dollar (USD/ZAR) becomes key. If the rand weakens, SA tech firms or investors eyeing international quantum plays will pay more in local terms. The bullish scenario of cloud revenue and government funding could move the needle, but it’s a long shot. Given the milestone risks and dilution ahead, this is speculative tech at best. This story reinforces why local banks like Standard Bank or FirstRand, with clearer earnings and dividends, remain safer bets for steady portfolios. Rigetti’s fate hinges on breakthroughs, and those are far from guaranteed—. this is just my opinion and not financial advice
Avoid Rigetti shares for now. Instead, watch USD/ZAR trends to gauge foreign tech exposure costs and stay with reliable dividend payers on the JSE like Standard Bank or FirstRand.
- USD/ZAR
- Standard Bank
- FirstRand
- Milestone execution failure at Rigetti
- Share dilution eroding value
- Rand volatility increasing foreign investment costs
5/10
Rigetti Computing stock has declined from $56 to $14 since October. The article analyzes three scenarios for the quantum computing company: a base case of continued milestone delivery with minimal revenue against high R&D spending, a bullish case where cloud services generate recurring revenue, and a bearish case of missed milestones and share dilution. The company has $569 million in cash, $4.4 million in Q1 revenue, and $19.9 million in R&D spending, with upcoming catalysts including a planned 1,000+ qubit U.K. system and potential $100 million in government funding.
This article was originally published by The Motley Fool and has been adapted here for Axe Capital Trading News.
Publisher: The Motley Fool
Author: Alex Carchidi
Categories: Equities, Earnings
Tickers: RGTI, RGTIW
Sentiment: Neutral - The article presents a balanced view with three scenarios. While the company has strong cash reserves ($569 million) and government validation, it faces significant challenges: massive R&D spending ($19.9M) against minimal revenue ($4.4M), high execution risk on milestones, and inevitable share dilution. The base case suggests continued survival but no near-term profitability, making it a speculative investment dependent on future technical breakthroughs rather than current fundamentals.
Keywords: quantum computing, milestone delivery, government funding, share dilution, R&D spending, cloud services, qubit systems
Insights:
- RGTI: Neutral: The article presents a balanced view with three scenarios. While the company has strong cash reserves ($569 million) and government validation, it faces significant challenges: massive R&D spending ($19.9M) against minimal revenue ($4.4M), high execution risk on milestones, and inevitable share dilution. The base case suggests continued survival but no near-term profitability, making it a speculative investment dependent on future technical breakthroughs rather than current fundamentals.
- RGTIW: Neutral: The article presents a balanced view with three scenarios. While the company has strong cash reserves ($569 million) and government validation, it faces significant challenges: massive R&D spending ($19.9M) against minimal revenue ($4.4M), high execution risk on milestones, and inevitable share dilution. The base case suggests continued survival but no near-term profitability, making it a speculative investment dependent on future technical breakthroughs rather than current fundamentals.